Inhibition of hexokinase-2 with targeted liposomal 3-bromopyruvate in an ovarian tumor spheroid model of aerobic glycolysis
Srujan Kumar Gandham, Meghna Talekar, Amit Singh, Mansoor M Amiji Department of Pharmaceutical Sciences, School of Pharmacy, Northeastern University, Boston, MA, USA Background: The objective of this study was to evaluate the expression levels of glycolytic markers, especially hexokinase-...
Main Authors: | Gandham SK, Talekar M, Singh A, Amiji MM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-07-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/inhibition-of-hexokinase-2-with-targeted-liposomal-3-bromopyruvate-in--peer-reviewed-article-IJN |
Similar Items
-
In vitro evaluations of hexokinase-2 inhibition with 3-bromopyruvate encapsulated in targeted liposomal formulations using 3D spheroid models of tumor aerobic glycolysis
Published: () -
Tumor Energy Metabolism and Potential of 3-Bromopyruvate as an Inhibitor of Aerobic Glycolysis: Implications in Tumor Treatment
by: Tengjiao Fan, et al.
Published: (2019-03-01) -
The Role of Hexokinase II in the Regulation of Glycolysis and Cisplatin Sensitivity in Ovarian Cancer
by: Han, Chae Young
Published: (2018) -
Sinomenine Inhibits Non-Small Cell Lung Cancer via Downregulation of Hexokinases II-Mediated Aerobic Glycolysis
by: Liu W, et al.
Published: (2020-04-01) -
Hexokinase 2 is a Key Mediator of Aerobic Glycolysis Promoting Tumour Growth in Glioblastoma Multiforme
by: Wolf, Amparo
Published: (2010)